Immunoglobulin M and G immunoblots in the diagnosis of parvovirus B19 infection

Journal of the Formosan Medical Association

Volumn 99, Issue 1, 2000, Pages 24-32

  Chen, Mao Yuan ^a   Lee, Kuang Lun ^a   Hung, Chien Ching ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

ELISA; Immunoblot; Nested PCR; Parvovirus B19

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS PROTEIN;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHRONIC ARTHRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA INFECTIOSUM; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOCOMPETENCE; MALE; POLYMERASE CHAIN REACTION;

ADULT; ANTIBODIES, VIRAL; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHEMA INFECTIOSUM; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION;

EID: 0034116242     PISSN: 09296646     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Anderson MJ, Lewis E, Kidd IM, et al: An outbreak of erythema infectiosum associated with human parvovirus infection. J Hyg (Camb) 1984;93:85-93.
2. White DG, Woolf AD, Mortimer PP, et al: Human parvovirus arthropathy. Lancet 1985;i:419-21.
3. Naides SJ, Scharosch LL, Foto F, et al: Rheumatological manifestations of human parvovirus B19 infection in adults. Arthritis Rheum 1990;33:1297-309.
4. Nesher G, Osborn TG, Moore TL: Parvovirus infection mimicking systemic lupus erythematosus. Semin Arthritis Rheum 1995;24:297-303.
5. Anand A, Gray ES, Brown T, et al: Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 1987;316:183-6.
6. Young N: Hematological and hematopoietic consequences of B19 parvovirus infection. Semin Hematol 1988; 25:159-72.
7. Kurtzman GL, Ozawa K, Cohen B, et al: Chronic bone marrow failure due to persistent B19 parvovirus infection. N Engl J Med 1987;317:287-94.
8. Ozawa K, Young NS: Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow culture. J Virol 1987;61: 2627-30.
9. Anderson MJ, Higgins LR, William JS, et al: Experimental parvoviral infection in humans. J Infect Dis 1985;152: 257-65.
10. Kurtzman GJ, Cohen BJ, Field AM, et al: Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 1989;84:1114-23.
11. Saikawa T, Anderson S, Momoeda M, et al: Neutralizing linear epitopes of B19 parvovirus cluster in the VP1 unique and VP1-VP2 junction regions. J Virol 1993;67: 3004-9.
12. Poblotzki AV, Hemauer A, Gigler A, et al: Antibodies to the nonstructural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis. J Infect Dis 1995;172:1356-9.
13. Frickhofen N, Abkowitz JL, Safford M, et al: Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Intern Med 1990;113:926-32.
14. Anderson MJ, Jones SE, Minson AC: Diagnosis of human parvovirus infection by dot-blot hybridization using cloned viral DNA. J Med Virol 1985;15:163-72.
15. Cassinotti P, Weitz M, Siegl G: Human parvovirus B19 infections: routine diagnosis by a new nested polymerase chain reaction assay. J Med Virol 1993;40:228-34.
16. Cassinotti P, Bas S, Siegl G, et al: Association between human parvovirus B19 infection and arthritis. Ann Rheum Dis 1995;54:498-500.
17. Zerbini M, Musiani M, Gentilomi G, et al: Comparative evaluation of virological and serological methods in prenatal diagnosis of parvovirus B19 fetal hydrops. J Clin Microbiol 1996;34:603-8.
18. Yoto Y, Kudoh T, Haseyama K, et al: Human parvovirus B19 infection associated with acute hepatitis. Lancet 1996; 347:868-9.
19. Musiani M, Zerbini M, Gentilomi G, et al: Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis 1995;172:1360-3.
20. Adler SP, Manganello AMA, Koch WC, et al: Risk of human parvovirus B19 infections among school and hospital employees during endemic periods. J Infect Dis 1993;168:361-8.
21. Shade RO, Blundell MC, Cotmore SF, et al: Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 1986;58:921-36.
22. Cohen BJ, Bates CM: Evaluation of 4 commercial test kits for parvoviral B19-specific IgM. J Virol Methods 1995;55:11-25.
23. Bruu AL, Nordbo SA: Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19. J Clin Microbiol 1995;33:1363-5.
24. Soderlund M, Brown CS, Cohen BJ, et al: Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J Infect Dis 1995;171:710-3.
25. Soderlund M, Brown CS, Spaan WJM, et al: Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19. J Infect Dis 1995;172:1431-6.
26. Faden H, Gary GW, Anderson LJ: Chronic parvovirus infection in a presumably immunologically healthy woman. Clin Infect Dis 1992;15:595-7.
27. Foto F, Saag KG, Scharosch LL, et al: Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients: evidence for B19 virus persistence. J Infect Dis 1993;167:744-8.
28. Nikkari S, Roivainen A, Hannonen P, et al: Persistence of parvovirus B19 in synovial fluid and bone marrow. Ann Rheum Dis 1995;54:597-600.
29. Saldanha J, Minor P: Detection of human parvovirus B 19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufacture. Br J Haematol 1996;93:714-9.